We are live on ! Find out more
BIOL

Biolase, Inc.
BIOL

Delisted

BIOL was delisted on the 18th of June, 2024.

Back to rankings

38 hedge funds and large institutions have $14.4M invested in Biolase, Inc. in 2021 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

140% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 5

80% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 5

23% more funds holding

Funds holding: 31 → 38 (+7)

17% more capital invested

Capital invested by funds: $12.4M → $14.4M (+$2.06M)

Holders
38
Holders Change
+7
Holders Change %
+22.58%
% of All Funds
0.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
9
Reduced
5
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$1.01M
2
GCP
GSA Capital Partners
United Kingdom
+$820K
3
EIM
Essex Investment Management
Massachusetts
+$522K
4
Marshall Wace
Marshall Wace
United Kingdom
+$491K
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$219K

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$96.3K
2
State Street
State Street
Massachusetts
-$80K
3
AG
Algert Global
California
-$13K
4
LFG
Larson Financial Group
Missouri
-$13K
5
Renaissance Technologies
Renaissance Technologies
New York
-$11.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
TSS
26
Two Sigma Securities
New York
$19K +$19.6K +12 New
Goldman Sachs
27
Goldman Sachs
New York
$15K -$96.3K -59 -86%
Victory Capital Management
28
Victory Capital Management
Texas
$14K – – –
Bank of Montreal
29
Bank of Montreal
Ontario, Canada
$12K – – –
CFGS
30
Concourse Financial Group Securities
Alabama
$9K – – –
ZF
31
Zhang Financial
Michigan
$8K +$8.16K +5 New
WSC
32
Wellington Shields & Co
New York
$6K – – –
TFO
33
Tarbox Family Office
California
$5K – – –
Fidelity Investments
34
Fidelity Investments
Massachusetts
$5K +$4.9K +3 New
UBS Group
35
UBS Group
Switzerland
$4K -$8.16K -5 -71%
Osaic Holdings
36
Osaic Holdings
Arizona
$3K +$3.27K +2 New
IA
37
IFP Advisors
Florida
$2K – – –
TRCT
38
Tower Research Capital (TRC)
New York
$2K +$1.63K +1 New
1832 Asset Management
39
1832 Asset Management
Ontario, Canada
$1K – – –
Wells Fargo
40
Wells Fargo
California
$1K – – –
APA
41
American Portfolios Advisors
New York
$256 – – –
AG
42
Algert Global
California
– -$13K -7 Closed
LFG
43
Larson Financial Group
Missouri
– -$13K -7 Closed
SC
44
Scotia Capital
Ontario, Canada
– -$7K -4 Closed
SXL
45
Summit X LLC
Missouri
– -$7K -4 Closed
SWM
46
Spire Wealth Management
Virginia
– -$3K -2 Closed
1
2

BIOL Hedge Fund Activity: Q3 2021 in Review

38 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Biolase, Inc. (BIOL) for Q3 2021, worth a combined $14.4M — up 17% from $12.4M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new BIOL positions and 5 closed out — a net gain of 7 holders — while 9 added to existing stakes and 5 trimmed.

The largest buyer was Millennium Management, adding an estimated $1.01M. The largest seller was Goldman Sachs, cutting an estimated $96.3K.

  • 38 institutional investors held Biolase, Inc. (BIOL) as of Q3 2021, up from 31 in Q2 2021.
  • Funds reported $14.4M of Biolase, Inc. stock for Q3 2021, up 17% quarter-over-quarter.
  • 12 funds opened new Biolase, Inc. positions in Q3 2021 and 5 closed out, a net change of +7 holders.
  • The largest Biolase, Inc. buyer in Q3 2021 was Millennium Management, an estimated $1.01M added.
  • The largest Biolase, Inc. seller in Q3 2021 was Goldman Sachs, an estimated $96.3K sold.

Based on aggregated 13F filings for Q3 2021.